Cisplatin induces the pro-apoptotic conformation of the Bcl-2 family protein Bak in four out of four human melanoma cell lines, whereas an effect on the pro-apoptotic conformation of Bax was seen in only one (FM55 cells). Expression of a kinase-inactive fragment of MEKK1 (dnMEKK) efficiently blocked the modulation of Bak and cytochrome c release, whereas DEVDase activation and nuclear fragmentation were reduced by half. Expression of a kinase-active MEKK1 fragment (dpMEKK) was sufficient to modulate Bak in three out of four cell lines, whereas an effect on Bax was seen only in FM55 cells. In the DFW cell line, dpMEKK stimulated a similar degree of Bak modulation as cisplatin but did not induce nuclear fragmentation. Together with the knowledge that dnMEKK was insufficient to block apoptosis completely, this finding indicates that cisplatin may induce apoptosis by means of additional mechanisms. We conclude that a proapoptotic MEKK1 pathway is necessary for cisplatin-induced Bak modulation, and that this modulation represents one of several cisplatin-induced apoptotic mechanisms or processes.
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Genotoxic damage, as induced by cisplatin, has been reported to lead to upregulation of pro-apoptotic members of the Bcl-2 family. We have here examined the pro-apoptotic Bcl-2 proteins Bak and Bax in human melanoma cells treated with cisplatin. Expression of Bak was not increased by this treatment; instead, equitoxic doses of cisplatin were found to induce the pro-apoptotic conformation of Bak in all human melanoma cell lines tested, irrespective of p53 status. Unlike Bak modulation, cisplatin-mediated modulation of Bax was seen in only one of the p53 wildtype cell lines. The upstream regulation of Bak is not known. We show that expression of a kinase-inactive fragment of the stress-activated kinase MEKK1 (dnMEKK) blocks modulation of Bak and apoptosis. Activation of the downstream kinases JNK1-2, which regulate activity of transcription factor c-Jun, has been shown to be involved in cisplatin-induced apoptosis. Although dnMEKK inhibited apoptosis, JNK1-2 activation was not blocked. Conversely, expression of a kinase-active MEKK1 fragment (dpMEKK) was able to modulate Bak and to induce apoptosis in a cell-line-dependent manner. We conclude that a pro-apoptotic MEKK1 pathway is necessary for cisplatin-induced Bak modulation, and that this modulation represents one of several cisplatin-induced apoptotic mechanisms/processes. A detailed transcript map of the human chromosome 12p12.3 tumor suppressor locus: the usefulness of an integrative approach
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